PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The B7 family member programmed death ligand 2 (PD‐L2) has been implicated in both positive and negative regulation of T cell activity. In this study, we demonstrate that on human T cells, PD‐L2 acts only as a negative regulator of T cell activity, inhibiting proliferation, IL‐2 production, and IFN‐γ production via its interaction with programmed death‐1 (PD‐1). This study also shows a novel role for PD‐1 in inhibiting β1 and β2 integrin‐mediated adhesion. PD‐L2 inhibition of T cell function involves modulation of the phosphoinositide 3‐OH kinase (PI 3‐K)/AKT and extracellular signal‐related kinase (ERK)/mitogen‐activated protein kinase (MAPK) pathways, with PD‐L2 inhibiting anti‐CD3‐induced AKT phosphorylation within minutes and ERK phosphorylation after hours. Analysis of phosphatase activity of Src homology 2 domain‐containing tyrosine phosphatase (SHP)‐1 and SHP‐2 in response to anti‐CD3 mAb or anti‐CD3 mAb + PD‐L2 stimulation revealed that while SHP‐1 phosphatase activity is not affected by stimulation, SHP‐2 phosphatase activity is significantly increased by anti‐CD3 mAb + PD‐L2 stimulation. Anti‐CD3 mAb + PD‐L2 stimulation also increased the level of SHP‐2 associated with the PD‐1 receptor. These results suggest that catalytically active SHP‐2 associated with the PD‐1 receptor is involved in modulating T cell function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice
Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., & Pouysségur, J. (1999) · Science · doi:10.1126/science.286.5443.1374 · Cited by 654
Signal transduction by the TCR for antigen
Kane, L. P., Lin, J., & Weiss, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00083-2 · Cited by 498
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines
Kane, L. P., Andres, P. G., Howland, K. C., Abbas, A. K., & Weiss, A. (2001) · Nature Immunology · doi:10.1038/83144 · Cited by 316
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
“PD-1 could exert its inhibitory effects by bringing SHP-2 into the synapse during antigen receptor signaling, and cross-linking of PD-1 and CD3 increases the amount of SHP-2, but not SHP1, associated with PD-1 (39).”
BackgroundA Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Esfahani, K., Roudaia, L., Buhlaiga, N., Del Rincon, S. V., Papneja, N., & Miller, W. H. (2020) · Current Oncology · doi:10.3747/co.27.5223 · Cited by 954
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 721
Yang, Y., Li, C.-W., Chan, L.-C., Wei, Y., Hsu, J.-M., Xia, W., Cha, J.-H., Hou, J., Hsu, J. L., Sun, L., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0060-4 · Cited by 512
Wu, M., Huang, Q., Xie, Y., Wu, X., Ma, H., Zhang, Y., & Xia, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01242-2 · Cited by 456
Metadata
- Authors
- Saunders, P. A., Hendrycks, V. R., Lidinsky, W. A., & Woods, M. L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-12
- Volume
- 35
- Issue
- 12
- Pages
- 3561-3569
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2025890468
- Cited by
- 114
- References
- 6
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion. https://app.cochat.ai/papers/10.1002/eji.200526347
- The paper
- Saunders, P. A., Hendrycks, V. R., Lidinsky, W. A., & Woods, M. L. (2005). PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion. European Journal of Immunology. https://doi.org/10.1002/eji.200526347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.